Cancer is the leading cause of death for Americans between the ages of 40 and 79. Lung cancer is the leading cause of cancer death for both men and women in the US.

Lung cancer is the world's deadliest cancer. It kills more Americans than the next three cancers combined - breast, prostate and colon - at half the incidence rate.

About Orbit Genomics

Orbit Genomics’ mission is to leverage our proprietary OrbiSeq technology platform for early disease detection and ultimately for prevention.

Technology

Our OrbiSeq technology platform analyzes repetitive DNA called microsatellites which uniquely reflect both inherited and acquired disease risk.

Contact Us

For more information on our  products and services,   or if you would  like copies of our publications,   please contact us.

Microsatellites - your DNA's early warning system

Learn More

ORBIT GENOMICS

klsjdajsdhaksjdhasj

Since the first sequencing of the human genome in 2003, tremendous gains have been made in understanding hereditary cancer syndromes, with over 50 having been identified. Genetic tests to assess a person’s inherited risk of developing certain cancers are abundant. However, the tests are not clinically actionable for most healthy people. Genetic mutations measure population risk, not individual risk. Genetic mutations (SNPs) identify increased disease risk, but their presence doesn’t guarantee disease will occur, and their absence doesn’t guarantee disease will not occur. Complex diseases are caused by a combination of genetic mutations and environmental factors, including lifestyle. Orbit Genomics’ proprietary OrbiSeq technology platform analyzes novel genomic markers called microsatellites that uniquely reflect both inherited risk and risk acquired due to lifestyle and environmental exposures. Microsatellites are much more responsive than SNPs, measuring individual disease risk. They are your DNA’s early warning system.

  • Science & Technology

    Accelerating precision medicine by developing clinically actionable tests.

  • Product Pipeline

    Improving lung cancer diagnosis.

  • About Us

    Founded in 2016 as a collaboration between Dr. Harold “Skip” Garner and Ventac Partners.

  • Contact Us

    +1 720.515.0395
    info@orbitgenomics.com

NEWS

Orbit Genomics is presenting at the Rocky Mountain Life Science Investor and Partnering Conference on Sep 5

https://www.cobioscience.com/events-calendar/RMLIPC2019

Orbit Genomics is recognized by MedTech Innovator as one of the 50 best-in-class startups in the medtech industry.

https://medtechinnovator.org/medtech-innovator-2019-showcase-and-accelerator/

CSO, Skip Garner, in the News

Researchers in Blacksburg Develop Lung Cancer Risk Genetic Test